<DOC>
	<DOCNO>NCT00117754</DOCNO>
	<brief_summary>Tinea capitis dermatophyte infection scalp hair follicle , occur primarily child . Hair loss , hair breakage , scaling , plus various degree erythema , pustule pruritus primary clinical sign associate tinea capitis . The infection cause relatively small group dermatophytes genera Trichophyton Microsporum . Terbinafine hydrochloride synthetic allylamine derivative antifungal agent . This study evaluate efficacy safety terbinafine child tinea capitis .</brief_summary>
	<brief_title>Terbinafine Compared Griseofulvin Children With Tinea Capitis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Capitis</mesh_term>
	<mesh_term>Terbinafine</mesh_term>
	<mesh_term>Griseofulvin</mesh_term>
	<criteria>Patients clinical diagnosis tinea capitis confirm positive KOH determine central mycology laboratory . Male female patient least 4 year old 12 year old . Patients medical condition alters absorption and/or metabolism terbinafine ( e.g . liver , renal disease etc . ) Patients receive medication may interfere evaluation drug â€™ effect Patients kerion require immediate treatment treatment systemic corticosteroid and/or systemic antibiotic Patients history liver disease current/active liver disease elevation livery enzymes outside normal range correspond age Patients receive recent systemic topical treatment tinea capitis within specified time period ( e.g . systemic antifungal within 2 month screen visit , topical treatment [ e.g . antifungal , corticosteroid preparation , zinc pyrithione selenium sulfide tar contain product ] within 1 week screening ) . Patients history systemic lupus erythematosus</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Terbinafine , Tinea capitis , pediatric , antifungal</keyword>
</DOC>